Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HEXO Equities Warrants Exp 2 Apr 2024 T.HEXO


Primary Symbol: T.HEXO.W.A

Hexo Corp. is a Canada-based consumer packaged goods cannabis company. The Company is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The Company serves the Canadian recreational market with a brand portfolio, including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market under HEXO medical cannabis in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes, and HEXO Plus high potency flower, exclusive to Quebec. Its brand Namaste is a recreational cannabis brand for mindful consumers.


TSX:HEXO.W.A - Post by User

Post by Keeleron Aug 15, 2022 8:14am
120 Views
Post# 34896001

Failed strategy

Failed strategy

The Hexo CEO of the month agrees that buying pos bankrupt companies such as Zenabis and 48n just to increase revenue is idiotic and incompetent management strategy. Too bad no one told SSL.
Of course Simple Simon, Tilray CEO is trying the same thing - Hexo, Medmen, no wonder Tilray has a SELL from analysts.

The previous administration said all revenue is good revenue, and that's a bad, bad thing," Bowman said in a call from Colorado.

"All revenue is not good. You need profitable revenue, you need revenue, which ... might not make money today, but it's going to make money in two steps."

<< Previous
Bullboard Posts
Next >>